Unichem Laboratories is currently trading at Rs. 212.00, up by 4.90 points or 2.37% from its previous closing of Rs. 207.10 on the BSE.
The scrip opened at Rs. 209.95 and has touched a high and low of Rs. 219.45 and Rs. 206.40 respectively. So far 9492 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 382.00 on 08-Jan-2018 and a 52 week low of Rs. 182.00 on 11-Oct-2018.
Last one week high and low of the scrip stood at Rs. 219.45 and Rs. 187.20 respectively. The current market cap of the company is Rs. 1512.38 crore.
The promoters holding in the company stood at 50.67%, while Institutions and Non-Institutions held 10.22% and 39.11% respectively.
Unichem Laboratories has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) indicating closure of inspections at both the API manufacturing facilities located at Pithampur and Roha.
The inspection at Pithampur was conducted by the USFDA from July 23, 2018 to July 27, 2018, while the inspection at Roha was conducted by the USFDA from July 30, 2018 to August 3, 2018.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.